In the latest close session, Allstate (ALL) was up +1.48% at $196.20. The stock exceeded the S&P 500, which registered a gain of 0.14% for the day. Elsewhere, the Dow gained 0.2%, while the tech-heavy ...

Analysts have set 12-month price targets for Allstate, revealing an average target of $216.88, a high estimate of $250.00, ...

Allstate Corporation ended 2024 on a high note, reporting strong financial and strategic performance in the fourth quarter and full year. The company posted $16.5 billion in total revenue for Q4 ...

The Allstate Corporation ALL recently closed the sale of its Group Health business to Nationwide for a total consideration of ...

Allstate offers strong yields on preferreds and bonds, backed by solid ratings and insurer strength despite weather losses.

Allstate Corp. closed 7.97% below its 52-week high of $213.18, which the company reached on June 3rd.

Morgan Stanley analyst Bob Huang has maintained their bullish stance on ALL stock, giving a Buy rating on October 18. Bob Huang has given his B ...

Nevertheless, Allstate’s overall performance has remained more than impressive. The company reported a staggering 14.7% year-over-year growth in consolidated revenues to $16.6 billion.

Shields highlighted Allstate’s performance, ... The firm also raised its operating EPS estimates for 2025 and 2026, suggesting confidence in Allstate’s future financial performance.

This adjustment was based on Allstate's recent financial performance and strategic initiatives, with the firm projecting a modest increase in earnings per share estimates for 2026 and 2027.

For valuable insights into Allstate's market performance, consider these analyst evaluations alongside crucial financial indicators. Stay well-informed and make prudent decisions using our Ratings ...

BMO maintains Allstate stock Outperform rating, $222 target ...